CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,046 | -90.1% | 1,881 | -92.7% | 0.00% | -88.9% |
| Q2 2023 | $283,375 | +1770993.8% | 25,879 | +1315.7% | 0.01% | +800.0% |
| Q1 2023 | $16 | +23.1% | 1,828 | -11.1% | 0.00% | 0.0% |
| Q4 2022 | $13 | -99.9% | 2,057 | -68.5% | 0.00% | – |
| Q3 2022 | $23,000 | -36.1% | 6,527 | -47.3% | 0.00% | -100.0% |
| Q2 2022 | $36,000 | -56.1% | 12,386 | -53.1% | 0.00% | 0.0% |
| Q1 2022 | $82,000 | +412.5% | 26,382 | +474.4% | 0.00% | – |
| Q4 2021 | $16,000 | -65.2% | 4,593 | -63.7% | 0.00% | -100.0% |
| Q3 2021 | $46,000 | -45.9% | 12,645 | -35.1% | 0.00% | -50.0% |
| Q2 2021 | $85,000 | +193.1% | 19,475 | +201.5% | 0.00% | – |
| Q1 2021 | $29,000 | -69.5% | 6,459 | -61.3% | 0.00% | -100.0% |
| Q4 2020 | $95,000 | -82.6% | 16,686 | -77.8% | 0.00% | -50.0% |
| Q3 2020 | $545,000 | +948.1% | 75,209 | +406.3% | 0.01% | +200.0% |
| Q2 2020 | $52,000 | +550.0% | 14,855 | +168.7% | 0.00% | – |
| Q1 2020 | $8,000 | -86.9% | 5,528 | -53.7% | 0.00% | -100.0% |
| Q3 2019 | $61,000 | +74.3% | 11,950 | +281.5% | 0.00% | +33.3% |
| Q3 2018 | $35,000 | -50.0% | 3,132 | -41.8% | 0.00% | -50.0% |
| Q1 2018 | $70,000 | +180.0% | 5,384 | +101.6% | 0.01% | +100.0% |
| Q4 2017 | $25,000 | -35.9% | 2,671 | -45.5% | 0.00% | 0.0% |
| Q3 2017 | $39,000 | +3800.0% | 4,898 | +1165.6% | 0.00% | – |
| Q3 2016 | $1,000 | -87.5% | 387 | -93.3% | 0.00% | -100.0% |
| Q1 2016 | $8,000 | +100.0% | 5,777 | +133.6% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | – | 2,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |